News | News By Subject | News by Disease News By Date | Search News

Swine Flu News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
European Medicines Evaluation Agency Finds No Narcolepsy Link to GlaxoSmithKline (GSK)'s Flu Vaccine     9/24/2010
Pfizer Inc. (PFE) Sells China Swine Vaccine Unit to Harbin Tian Qing Biotech Application Company for $50 Million     6/1/2010
Tail-End of Swine Flu Helps GlaxoSmithKline (GSK) Beat Forecasts     4/28/2010
Novavax, Inc. (NVAX) Cites Positive Phase 2 Swine Flu Vaccine Data     3/24/2010
France Cuts Swine Flu Vaccine Order from Novartis Corporation (NVS) (JOBS)     1/8/2010
MedImmune (JOBS) Recalling Swine Flu Vaccine- Says FDA     12/23/2009
Sanofi-Aventis (France) (SASY.PA) Recalls 800000 H1N1 Vaccine Over Potency     12/15/2009
Canada Stops Use of One Batch of GlaxoSmithKline (GSK) (JOBS) Flu Vaccine     11/25/2009
GlaxoSmithKline (GSK) (JOBS) Wins U.S. Approval for Swine Flu Vaccine     11/12/2009
GlaxoSmithKline (GSK) Takes Biggest Slice of Swine Flu Market     10/30/2009
Severe Swine Flu Patients Eligible for Biocryst Pharmaceuticals (BCRX) Drug, FDA Says     10/26/2009
Governments Up Orders to About 440 Million Doses Of GlaxoSmithKline (GSK)'s (JOBS) Swine Flu Vaccine     10/6/2009
EU Agency Recommends Baxter International, Inc. (BAX)'s (JOBS) H1N1 Flu Shot     10/2/2009

News from Around the Web
Swine Flu Variation Emerges With Power to Resist Drugs from Roche Holding AG (RHHBF.PK) and GlaxoSmithKline (GSK)     6/10/2011
Swine Flu Drug Advisors to World Health Organization Were Linked to Drug Makers Who Profited from Vaccines     6/8/2010
Extra Mutations Help Flu Evade Drug, Study in Science     6/4/2010
Swine Flu Fears Push Seasonal Shots to Record High, Say Centers for Disease Control and Prevention (CDC) Researchers     4/30/2010
Swine Flu Resistance Develops Quickly, National Institute of Allergy And Infectious Diseases (NIAID) Report     3/29/2010
The Scripps Research Institute Research Team Finds Structure Of 'Swine Flu' Virus     3/25/2010
Swine Flu Vaccine Plentiful In The U.S.     12/18/2009
Norweigian Scientists Announce H1N1 Mutation     11/24/2009
Not Just Swine Flu - New Cold Virus May Lurk, Too, Children's Hospital of Philadelphia Doctors Discover     11/18/2009
Antivirals Key To Preventing Severe H1N1 Disease, World Health Organization Says     11/16/2009
H1N1 Vaccine: One Big Confusing Mess     11/10/2009
Pet Cat in U.S. Catches Swine Flu     11/5/2009
First Draft of the Pig: Researchers Sequence Swine Genome, University of Illinois Study     11/2/2009
Alabama Scientists Discover Influenza's Achilles Heel: Antioxidants     10/30/2009
Triple-combo Drug Shows Promise Against Antiviral-resistant H1N1, University of Alabama at Birmingham Study     10/30/2009

Press Releases
FDA Takes Steps To Withdraw Approval Of The Swine Drug Carbadox Due To Safety Concerns     4/11/2016
AVI BioPharma, Inc. (AVII) Announces Positive Results Against Human Pandemic H1N1 Influenza Virus in Preclinical Studies of AVI-7100     8/24/2010
Publication of Vical Incorporated (VICL)'s H5N1 Results Paves the Way for H1N1 Clinical Trial     2/24/2010
Novartis AG Says on Track to Deliver US Vaccine Order     10/29/2009
Flugen, Inc. Cell-Based, Egg-Free Method Produces Novel 2009 H1N1 Vaccine Virus     10/29/2009
Novartis International AG (NVS) Says on Track to Deliver US Vaccine Order     10/29/2009
Harvard Health Publications Launches H1N1 Flu iPhone Application     10/28/2009
Novavax, Inc. (NVAX) And Xcellerex, Inc. Announce Collaboration to Develop Large-scale Manufacturing Process for 2009 H1N1 Influenza VLP Vaccine     10/21/2009
U.S. Navy to Fund Vical Incorporated (VICL)'s H1N1 Pandemic Influenza (Swine Flu) Vaccine     10/1/2009
XOMA (US) LLC (XOMA) to Develop Therapeutic Antibody for H1N1 and H5N1 Influenza Viruses Under $2.2 Million U.S. Government Program Managed by SRI International     9/24/2009
Simcere Pharmaceutical Group Invested Company Obtains Production License for H1N1 Flu Vaccine     9/22/2009
NexBio, Inc. Presents DAS181 (Fludase(R)*) Potently Inhibits Novel Swine-Origin A(H1N1) and NAI-Resistant Influenza Viruses, at ICAAC 2009     9/14/2009
Sinovac Biotech Ltd. (SNVBF): China Set to Approve 1-Dose Swine Flu Vaccines     9/2/2009
ImmuneRegen BioSciences, Inc. (IRBO) Confirms Homspera's Therapeutic Anti-Influenza Effect on Pandemic H1N1 Influenza Virus After Oral Administration     7/29/2009
Sinovac Biotech Ltd. (SNVBF) Initiates Dosing in Human Clinical Trial of Panflu for Pandemic Influenza A (H1N1)     7/22/2009

//-->